Factors influencing the lysis of ex vivo human thrombi

Fibrinolysis

Volumn 10, Issue 2, 1996, Pages 103-109

  Sabovic M ^a   Keber, D ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN[LYSINE]; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL;

EID: 0029882423     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80085-3     Document Type: Article

References (26)

1. Marder V J, Sherry S. Thrombolytic therapy: current status. N Engl J Med 1988; 318: 1512-1521.
2. Chesterman C N. Thrombolytic therapy. In: Haemostasis and Thrombosis, 2nd ed, Bloom A L, Thomas D P, eds. London: Churchill Livingstone 1987: 829-848.
3. Verstraete M. Use of thrombolytic drugs in non-coronary disorders. Drugs 1989; 38: 801-821.
4. Krings W, Peters P. Percutaneous reopening procedures. In: Dormandy J A, Stock G, eds. Critical leg ischaemia. Berlin: Springer 1990: 53-68.
5. Gardiner G A, Rao A K. Thrombolysis for peripheral arterial occlusions. Radiology 1990; 175: 34-36.
6. Hess H, Ingrisch H, Mietaschk, Rath H. Local low-dose thrombolytic therapy of peripheral arterial occlusions. New Engl J Med 1982; 307: 1627-1630.
7. McNamara T O, Fischer J R. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. Am J Roentgenol 1985; 144: 769-775.
8. Lammer J, Pilger E, Neumayer K, Schreyer H. Intra-arterial fibrinolysis: long term results. Radiology 1986; 161: 159-163.
9. Semba C P, Dake D D. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191: 487-494.
10. Anderle K, Frohlich A. Review of studies with plasminogen concentrates and proposals for further therapeutic strategies with plasminogen concentrates. Haemostasis 1988; 18 (suppl. 1): 165-175.
11. Weibel E R. Stereological methods. In: Practical methods for biological morphometry. London: Academic Press, 1980.
12. Knox P, Crooks S. Plasminogen activation and lysis of blood clots induced by cells in vitro. J Cell Physiol 1988; 135: 467-473.
13. Beer J H, Klay H P, Herren T, Haererli A, Straub P W. Whole blood clot lysis: enhanced by exposure to autologous but not to homologous plasma. Thromb Haemostas 1994; 71: 622-626.
14. Gottlob R. Plasminogen and plasmin inhibitors in arterial and venous thrombi of various ages. In: Davidson J F, Samama M M, Desnoyers P C, eds. Progress in chemical fibrinolysis and thrombolysis. New York: Raven Press 1975; (vol. 1): 23-35.
15. Brommer E J P, Bockel J H. Composition and susceptibility to thrombolysis of human arterial thrombi and the influence of their age. Blood Coagulation and Fibrinolysis 1992; 3: 717-725.
16. Theiss W, Worttzfeld A, Fink U, Maubach P. The success rate of flbrinolytic therapy of fresh and old thrombosis of the iliac and femoral veins. Angiology 1983; 34: 61-69.
17. Freiman D G. The structure of thrombi. In: Colman R W, Hirsch J, Marder V J, Salzman E W, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practise. Philadelphia: Lippincot 1987: 1123-1135.
18. Potter van Loon B J, Rijken D C, Brommer E J P, van der Maas A P C. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemostas 1992; 67: 101-105.
19. Sabovic M, Lijnen H R, Keber D, Collen D. Effect of retraction on the lysis of human clots with fibrin specific and non fibrin specific plasminogen activators. Thromb Haemostas 1989; 62: 1083-1087.
20. Sobel B E, Nachowiak D A, Fry E T A, Bergmann S R, Torr S R. Paradoxical attenuation of fibrinolysis attributable to 'plasminogen steal' and its implications for coronary thrombolysis. Coron Art Disease 1990; 1: 111-119.
21. Onundarson P T, Francis C W, Marder V J. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential. J Lab Clin Med 1992; 120: 120-128.
22. Blinc A, Planinsic G, Keber D et al. Dependence of blood clot lysis on the mode of transport of urokinase into the clot - a magnetic resonance imaging study in vitro. Thromb Haemostas 1991; 65: 549-552.
23. Kakkar V V, Sagar S, Lewis M. Treatment of deep vein thrombosis with intermittent streptokinase and plasminogen infusion. Lancet 1975; 2: 674-676.
24. Kakkar V V, Scully M F. Intermittent plasminogen-streptokinase treatment of deep vein thrombosis. Haemostasis 1988; 18 (suppl. 1); 127-138.
25. Onundarson P T, Haraldsson H M, Bergmann L, Francis C W, Marder V J. Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro. Thromb Haemostas 1993; 70: 998-1004.
26. Sabovic M, Lijnen H R, Keber D, Collen D. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb Haemostas 1990; 64: 450-454.